Full Text View
Tabular View
No Study Results Posted
Related Studies
An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome (aHUS)
This study is ongoing, but not recruiting participants.
Study NCT01193348   Information provided by Alexion Pharmaceuticals

First Received on August 31, 2010.   Last Updated on June 11, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Atypical Hemolytic-Uremic Syndrome
Additional conditions recognized in this trial
Azotemia
Hemolysis
Hemolytic-Uremic Syndrome
More general conditions related to this trial
Anemia
Anemia, Hemolytic
Blood Platelet Disorders
Hematologic Diseases
Kidney Diseases
Pathologic Processes
Thrombocytopenia
Thrombotic Microangiopathies
Uremia
Urologic Diseases
Interventions listed in this trial
Eculizumab
Sponsors listed in this trial
Alexion Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services